The primary objective of this study is to understand the evolution of initial treatment patterns among patients with early-stage (I-III) NSCLC.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Stage I-III at initial NSCLC diagnosis
Aged ≥18 years at first diagnosis of NSCLC
Timeframe of NSCLC diagnosis:
For DE1: diagnosed with NSCLC during the period between May 1st 2025 and December 31st 2025 For DE2: diagnosed with NSCLC during the period between May 1st 2026 and December 31st 2026 For DE3: diagnosed with NSCLC during the period between May 1st 2027 and December 31st 2027
You may not be if
NSCLC is not the primary cancer diagnosis
Patients with a recent history of other tumor or concurrent other tumor
Patients participating in interventional clinical trials at time of initial diagnosis
Patients with positive pregnancy status at the time of diagnosis